Skip to main content
Log in

Combined action of decreasing concentrations of azlocillin and sisomicin on pseudomonas aeruginosa as assessed in a dynamic in vitro model

Kombinierte Wirkung abnehmender Konzentrationen von Azlocillin und Sisomicin auf Pseudomonas aeruginosa in einem dynamischen In-vitro-Modell

  • Published:
Infection Aims and scope Submit manuscript

Summary

The effect of decreasing concentrations of azlocillin and sisomicin onPseudomonas aeruginosa was examined. Logarithmically growing bacterial cultures were incubated in an ultrafiltration cell, and after adding the antibiotics, the culture medium was diluted every 20 min without any decrease in cell density. The turn-over of medium resulted in the elimination of azlocillin with a half-life of 75 min. This simulated serum kineticsin vivo. When testing sisomicin, small amounts of this agent were added during every dilution step to achieve a half-life of 120 min. Growth conditions were comparable in all experiments. The simultaneous combination of azlocillin and sisomicin resulted in strong synergism as assessed by higher killing rates and more prolonged growth inhibition of surviving bacteria. Comparable results were observed when both drugs were added at intervals of 40 min. When applied at intervals of 120 min, the combined effect of azlocillin and sisomicin was reduced, but still superior to the effect of double the concentration of each compound alone. Thus, neither pre-treatment with azlocillin nor with sisomicin impaired the antibacterial activity of the combination partner. This seems to be of clinical importance since the agents may be administered at different times during combined therapy.

Zusammenfassung

Untersucht wurde die Wirkung abnehmender Konzentrationen von Azlocillin und Sisomicin aufPseudomonas aeruginosa. Nach Zugabe der Wirkstoffe zu einer logarithmisch wachsenden Bakterienkultur in einer Ultrafiltrationszelle wurde das Kulturmedium alle 20 min ohne Ausschwemmung von Keimen verdünnt. Durch den Austausch des Mediums wurde Azlocillin entsprechend derin vivo beobachteten Serumkinetik mit einer Halbwertszeit von 75 min eliminiert. Bei Prüfung von Sisomicin wurden geringe Mengen dieses Wirkstoffes bei jedem Verdünnungsschritt ergänzt, um eine Halbwertszeit von 120 min zu erzielen. In allen Versuchsansätzen herrschten vergleichbare Wachstumsbedingungen. Gleichzeitige Kombination von Azlocillin und Sisomicin führte zu einem starken Synergismus, der sich in höheren Abtötungsraten und länger anhaltender Wachstumshemmung der überlebenden Keime äußerte. Vergleichbare Ergebnisse wurden beobachtet, wenn beide Wirkstoffe im Abstand von 40 min zugesetzt wurden. Ein zeitlicher Abstand von 120 min führte zu einer Abschwächung des synergistischen Effektes, doch übertraf die Kombination in ihrer Wirkung noch immer die jeweils doppelten Konzentrationen der Einzelsubstanzen. Somit führte weder eine Vorbehandlung mit Azlocillin noch mit Sisomicin zu einer Beeinträchtigung der antibakteriellen Wirksamkeit des Kombinationspartners. Dies scheint von klinischer Bedeutung, da die Wirkstoffe bei kombinierter Therapie zu verschiedenen Zeitpunkten verabreicht werden können.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature

  1. Parker, R. F., Marsh, H. C. The action of penicillin on staphylococcus. J. Bacteriol. 51 (1946) 181–186.

    Google Scholar 

  2. Parker, R. F., Luse, S. The action of penicillin on staphylococcus: Further observations on the effect of a short exposure. J. Bacteriol. 56 (1948) 75–81.

    Google Scholar 

  3. Eagle, H., Musselman, A. D. The slow recovery of bacteria from the toxic effects of penicillin. J. Bacteriol. 58 (1949) 475–490.

    Google Scholar 

  4. Rolinson, G. N. Plasma concentrations of penicillin in relation to the antibacterial effect. In:Davies, D. S., Prichard, D. N. C. (eds.): Biological effects in relation to their plasma concentration. Macmillan, London 1973, pp. 183–189.

    Google Scholar 

  5. Shah, P. M., Hübner, K.-G., Stille, W. In-vitro-Untersuchungen zur intermittierenden Therapie mit Penicillin G und Ampicillin. Med. Welt 29 (1978) 888–892.

    Google Scholar 

  6. Wilson, D. A., Rolinson, G. N. The recovery period following exposure of bacteria to penicillins. Chemotherapy 25 (1979) 14–22.

    Google Scholar 

  7. Sanfilippo, A., Morvillo, E. An experimental model for the study of the antibacterial activity of the sulfonamides. Chemotherapy 13 (1969) 54–60.

    Google Scholar 

  8. Grasso, S., Meinardi, G., De Carneri, I., Tamassia, V. Newin vitro model to study the effect of antibiotic concentrations and rate of elimination on antibacterial activity. Antimicrob. Agents Chemother. 13 (1978) 570–576.

    Google Scholar 

  9. Bergan, T., Carlsen, I. B., Fuglesang, J. E. Anin vitro model for monitoring bacterial responses to antibiotic agents under simulatedin vivo conditions. Infection 8 Suppl. 1 (1980) S 96-S 102.

    Google Scholar 

  10. Bergan, T., Carlsen, I. B. Bacterial kill rates of amoxicillin and ampicillin at exponentially diminishing concentrations simulatingin vivo conditions. Infection 8 Suppl. 1 (1980) S 103-S 108.

    Google Scholar 

  11. Wiedemann, B. Microbiologic basis of antibiotic therapy. Infection 8 Suppl. 1 (1980) S 6-S 13.

    Google Scholar 

  12. Murakawa, T., Sakamoto, H., Hirose, T., Nishida, M. Newin vitro kinetic model for evaluating bactericidal efficacy of antibiotics. Antimicrob. Agents Chemother. 18 (1980) 377–381.

    Google Scholar 

  13. Klaus, U., Henninger, W., Jacobi, P., Wiedemann, B. Bacterial elimination and therapeutic effectiveness under different schedules of amoxicillin administration. Chemotherapy (Basel) 27 (1981) 200–208.

    Google Scholar 

  14. Nishida, M., Murakawa, T., Kamimura, T., Okada, N., Sakamoto, H., Fukada, S., Nakamoto, S., Yokota, Y., Miki, K. Laboratory evaluation of FR 10612, a new oral cephalosporin derivative. J. Antibiot. 29 (1976) 444–459.

    Google Scholar 

  15. Nishida, M., Murakawa, T., Kamimura, T., Okada, N. Bactericidal activity of cephalosporins in anin vitro model simulating serum levels. Antimicrob. Agents Chemother. 14 (1978) 6–12.

    Google Scholar 

  16. Randolph, J. A., Buck, R. E., Price, K. E., Leitner, F. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in anin vitro pharmacokinetic model. J. Antibiot. 32 (1979) 727–733.

    Google Scholar 

  17. O'Grady, F., Mackintosh, I. P., Greenwood, D., Watson, B. W. Treatment of “bacterial cystitis” in fully automatic mechanical models simulating conditions of bacterial growth in the urinary bladder. Br. J. Exp. Pathol. 54 (1973) 283–290.

    Google Scholar 

  18. Greenwood, D., O'Grady, F. Response of ampicillin resistantEscherichia coli to cephalosporins in anin vitro model simulating conditions of bacterial growth in the urinary bladder. Br. J. Exp. Pathol. 56 (1975) 167–171.

    Google Scholar 

  19. Shah, P. M., Peter, E., Stille, W. The bactericidal activity of decreasing concentrations of azlocillin and ticarcillin againstPseudomonas aeruginosa. In:Siegenthaler, W., Weuta, H. (eds.): International symposium acylureido-penicillins. Vienna 1979, Excerpta Medica, Amsterdam 1980, pp. 22–31.

    Google Scholar 

  20. Shah, P. M. An improved method to study antibacterial activity of antibiotics in anin vitro model simulating serum levels. Methods Findings Exp. Clin. Pharmacol. 2 (1980) 171–176.

    Google Scholar 

  21. Shah, P. M., Hessberger, U. Vergleichende Untersuchungen zur bakteriziden Aktivität von Ampicillin und Amoxycillin. Therapiewoche 31 (1981) 805–812.

    Google Scholar 

  22. Al-Asadi, M. J. S., Greenwood, D., O'Grady, F. In vitro model simulating the form of exposure of bacteria to antimicrobial drugs encountered in infection. Antimicrob. Agents Chemother. 16 (1979) 77–80.

    Google Scholar 

  23. Sakamoto, H., Hirose, T., Murakawa, T., Nishida, M. Bactericidal activity of antibiotics inin vitro model simulating antibiotic levels in body (3). Incorporation of cefazolin into the dialysis cell. Chemotherapy (Tokyo) 28 (1980) 842–827.

    Google Scholar 

  24. Daschner, F. In-vitro-Kombinationswirkung von Carbenicillin, Mezlocillin und Azlocillin mit Gentamicin und Sisomicin aufPseudomonas aeruginosa, Serratia marcescens, Klebsiella pneumoniae und indol-positiveProteus-Stämme. Infection 4 Suppl. 4 (1976) S 331-S 336.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haller, I. Combined action of decreasing concentrations of azlocillin and sisomicin on pseudomonas aeruginosa as assessed in a dynamic in vitro model. Infection 10 (Suppl 3), S229–S233 (1982). https://doi.org/10.1007/BF01640679

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01640679

Keywords

Navigation